BioCentury | Apr 24, 2020
Product Development
April 23 Quick Takes: Hansoh, NiKang partner for antiviral; plus Jakafi, Avastin, EpimAb-QIMR, ProThera-Takeda
...antiviral Hansoh Pharmaceutical Group Co. Ltd. (HKEX:03692) gained rights to develop and commercialize NKT-1992 from NiKang Therapeutics Inc....
...Pharmaceutical Co. Ltd. Hansoh Pharmaceutical Group Co. Ltd. Novartis AG Janus kinase-1 (JAK-1) Janus kinase-2 (JAK-2) Vascular endothelial growth factor (VEGF) NKT-1992 NiKang Therapeutics Inc....
...Pharmaceutical Co. Ltd. Hansoh Pharmaceutical Group Co. Ltd. Novartis AG Janus kinase-1 (JAK-1) Janus kinase-2 (JAK-2) Vascular endothelial growth factor (VEGF) NKT-1992 NiKang Therapeutics Inc....
